Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nu-Med Plus, Inc.NUMD · Entity 8515 | Director | November 07, 2023 | December 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nu-Med Plus, Inc.
Report date November 07, 2023 · Filed December 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,200,000 |
Reported balance
After 2023-11-07 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2023-11-07 · Grant · Acquired 200,000 · Balance 5,200,000 |
| Common StockSEC Table I · non-derivative | Direct | 5,000,000 |
Reported balance
Holding disclosure · report date 2023-11-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,000,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 07, 2023 Filed Dec 12, 2023 19:17 UTC | Nu-Med Plus, Inc. NUMD · Entity 8515 | GrantCommon Stock | 200,000 | $0.02 | $3,800.00 |
DisclosureSEC source: 0001548123-23-000177 · primary_doc.xml · nonDerivative · entry 2 Robins Jeffrey Lynn · CIK 0001560138 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,200,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.